A novel experimental model of acute hypertriglyceridemia induced by schisandrin B

European Journal of Pharmacology
Si-Yuan PanKam-Ming Ko

Abstract

Mice were intragastrically treated with single doses (0.05-0.8 g/kg) of schisandrin B (a dibenzocyclooctadiene derivative isolated from the fruit of Schisandra chinensis). Twenty-four hours after schisandrin B administration, the serum triglyceride level was increased by 10-235% in a dose-dependent manner. However, the serum low density lipoprotein cholesterol level was significantly decreased by 28% at a dose of 0.8 g/kg. When given once daily (0.01-0.2 g/kg) for 4 days, schisandrin B also dose-dependently elevated the serum triglyceride level (17-134%). Kinetics parameters estimated by Scott's plot analysis of schisandrin B-induced changes in serum and hepatic triglyceride levels were determined: serum-E(max) (maximal effect)=6 mmol/L (384% increase, P<0.001); K(D) (affinity)=0.59 mmol/kg; pD(2) (an index of affinity)=6.62; liver-E(max)=21 micromol/g (68% increase, P<0.001); K(D)=0.37 mmol/kg; pD(2)=6.83. The efficacy of schisandrin B in increasing the triglyceride level was 5.6-fold higher in serum than in liver tissue. Fenofibrate (0.2g/kg) treatment, when in combination with schisandrin B (0.2g/kg), for 4 days significantly reduced the schisandrin B-induced increase in serum triglyceride level (by 81%, P<0.001). Hepatic tr...Continue Reading

References

Jan 17, 1997·Science·L Masucci-MagoulasA R Tall
Nov 14, 1997·European Journal of Clinical Investigation·S EatonK Bartlett
Jul 16, 2003·Atherosclerosis·K L KhooE Janus
Dec 3, 2003·Atherosclerosis·Patricia BlackburnJean Pierre Després
Jan 8, 2004·Physiological Genomics·Takahiro UenoPavel Hamet
Jan 11, 2005·Current Vascular Pharmacology·Vasilis TsimihodimosMoses S Elisaf

❮ Previous
Next ❯

Citations

Jul 26, 2011·Evidence-based Complementary and Alternative Medicine : ECAM·Si-Yuan PanKam-Ming Ko
May 2, 2013·Evidence-based Complementary and Alternative Medicine : ECAM·Si-Yuan PanKam-Ming Ko
Feb 21, 2008·The Journal of Pharmacy and Pharmacology·Si-Yuan PanKam-Ming Ko
Jan 23, 2013·Journal of Proteome Research·Hiu Yee KwanWang Fun Fong

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.